The burgeoning virtual marketplace has presented novel avenues for accessing prescription drugs, including the stimulant Adderall, primarily recommended for attention deficit hyperactivity disorder (ADHD). While proponents of cognitive enhancement argue that these substances here can improve focus and productivity, ethical concerns arise surroundin